Prognostic factors associated with survival in patients with pancreatic cancer treated on early phase immune-checkpoint inhibitor clinical trials

被引：0
|
作者：
Surana, Rishi
Rogers, Jane E.
Nogueras-Gonzalez, Graciela M.
Hong, David S.
Yap, Timothy A.
Ahnert, Jordi Rodon
Naing, Aung
Wolff, Robert A.
Smaglo, Brandon George
Meric-Bernstam, Funda
Subbiah, Vivek
Pant, Shubham
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Canc Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Clin Pharm Programs, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.577
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
577
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Clinical adaptation of immune-checkpoint inhibitor for esophageal cancer
    Kato, Ken
    CANCER SCIENCE, 2022, 113
  • [2] Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials
    Sen, S.
    Pestana, R. Carmagnani
    Hess, K.
    Viola, G. M.
    Subbiah, V.
    ANNALS OF ONCOLOGY, 2018, 29 (12) : 2396 - 2398
  • [3] Factors associated with primary resistance to immune checkpoint blockade in early phase clinical trials
    Champiat, Stephane
    Matte, Paul
    Baldini, Capucine
    Vasseur, Damien
    Ouali, Kaissa
    Gazzah, Anas
    Bahleda, Rastilav
    Bayle, Arnaud
    Postel-Vinay, Sophie
    Smolenschi, Cristina
    Sakkal, Madona
    Michot, Jean-Marie
    Hollebecque, Antoine
    Chaput-Gras, Nathalie
    Loriot, Yohann
    Ponce, Santiago
    Italiano, Antoine
    Marabelle, Aurelien
    Danlos, Francois-Xavier
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [4] Factors associated with enrollment, participation, and survival of patients on early phase cancer clinical trials
    Baldwin, Elena
    Van Hyfte, Grace
    Lucas, Natalie
    Wu, Kathy
    Shelton, Gary
    Aird, Suzan
    Chung, Grace
    Fazilov, Gabriela
    Fitzgerald, Lisa
    Hapanowicz, Olivia
    Holley, Khadijah
    King, Paula
    Lu, Ashley
    Melukkaran, Nathasha
    San Lucas, Miriam
    Urena, Issamar
    Wawrzyniak, Aleksandra
    Posner, Marshall
    Galsky, Matthew D.
    Marron, Thomas U.
    Doroshow, Deborah B.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [5] Characteristics and outcomes of patients with recurrent ovarian cancer undergoing early phase immune checkpoint inhibitor clinical trials
    Hinchcliff, Emily
    Hong, David
    Le, Hung
    Chisholm, Gary
    Iyer, Revathy
    Naing, Aung
    Hwu, Patrick
    Jazaeri, Amir
    GYNECOLOGIC ONCOLOGY, 2018, 151 (03) : 407 - 413
  • [6] Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials
    Sen, Shiraj
    Hess, Kenneth
    Hong, David S.
    Naing, Aung
    Piha-Paul, Sarina
    Janku, Filip
    Fu, Siqing
    Subbiah, Ishwaria M.
    Liu, Holly
    Khanji, Rahil
    Huang, Le
    Moorthy, Shhyam
    Karp, Daniel D.
    Tsimberidou, Apostolia
    Meric-Bernstam, Funda
    Subbiah, Vivek
    BRITISH JOURNAL OF CANCER, 2018, 118 (06) : 763 - 769
  • [7] Cardiotoxicity in cancer patients treated with immune-checkpoint inhibitors
    Franco, F. F.
    Garitaonaindia, Y.
    Blanco Clemente, M.
    Torrente, M.
    Calvo de Juan, V.
    Collazo Lorduy, A.
    Gutierrez, L.
    Sanchez, J. C.
    del Alba Baamonde, M. A. Gonzalez
    Royuela, A.
    Visedo, G.
    Gonzalez, S. C.
    Martinez Cutillas, M.
    Traseira Puchol, C.
    Aguado, R.
    Mitroi, C. D.
    Provencio, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1406 - S1406
  • [8] Clinical Characteristics, Management and Prognostic Factors of Immune Checkpoint Inhibitor-Associated Pneumonia in Chinese Cancer Patients
    Li, Jinlan
    Chen, Shanshan
    Yan, Ting
    Zeng, Meizi
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (03): : 302 - 307
  • [9] Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials
    Shiraj Sen
    Kenneth Hess
    David S Hong
    Aung Naing
    Sarina Piha-Paul
    Filip Janku
    Siqing Fu
    Ishwaria M Subbiah
    Holly Liu
    Rahil Khanji
    Le Huang
    Shhyam Moorthy
    Daniel D Karp
    Apostolia Tsimberidou
    Funda Meric-Bernstam
    Vivek Subbiah
    British Journal of Cancer, 2018, 118 : 763 - 769
  • [10] PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS TREATED IN PHASE-I CLINICAL-TRIALS
    JANISCH, L
    MICK, R
    SCHILSKY, RL
    VOGELZANG, NJ
    OBRIEN, S
    KUT, M
    RATAIN, MJ
    CANCER, 1994, 74 (07) : 1965 - 1973
12345